Designing idiosyncratic hmPCL-siRNA nanoformulated capsules for silencing and cancer therapy

Idiosyncratic mesoporous-PCL nanocapsules (hmPCL) have been synthesised through microemulsion technique and formulated with siRNA. Nanoformulated siRNA-hmPCL is a potential vector for siRNA mediated therapy and for knock down of infected cells.216